Causal association between adiponectin and the risk of Alzheimer's disease: A Mendelian randomization study

BackgroundNumerous observational studies have revealed that circulating adiponectin (ADPN) is associated with Alzheimer's disease (AD) risk. However, the causality remains unknown. We aimed to assess the causality of circulating ADPN on AD risk using Mendelian randomization (MR).MethodsFourteen...

Full description

Bibliographic Details
Main Authors: Tianyu Jin, Wei Huang, Fangzheng Cao, Xinyue Yu, Zhenhua Ying, Shunyuan Guo, Yifan Cheng, Chao Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2022.1038975/full
_version_ 1811178317331562496
author Tianyu Jin
Tianyu Jin
Wei Huang
Fangzheng Cao
Xinyue Yu
Zhenhua Ying
Shunyuan Guo
Yifan Cheng
Chao Xu
author_facet Tianyu Jin
Tianyu Jin
Wei Huang
Fangzheng Cao
Xinyue Yu
Zhenhua Ying
Shunyuan Guo
Yifan Cheng
Chao Xu
author_sort Tianyu Jin
collection DOAJ
description BackgroundNumerous observational studies have revealed that circulating adiponectin (ADPN) is associated with Alzheimer's disease (AD) risk. However, the causality remains unknown. We aimed to assess the causality of circulating ADPN on AD risk using Mendelian randomization (MR).MethodsFourteen single nucleotide polymorphisms (SNPs) significantly associated with ADPN were selected from publicly available genetic abstract data. We applied these SNPs to two recent large-scale genome-wide association studies (GWAS) of AD, one from the FinnGen consortium and the other from a large meta-analysis. The inverse variance weighted method, MR–Egger method, the weighted median method, the Cochran Q statistic, the MR-Pleiotropy Residual Sum and Outlier methods, and the leave-one-out analysis were applied for MR analyses.ResultsIn MR analysis, no significant genetic association was found between plasma ADPN levels and AD risk by analyzing the FinnGen consortium GWAS database in the inverse variance weighted method [odds ratio (OR): 0.874, 95% confidence interval (CI): 0.701–1.089, p = 0.230], MR–Egger (OR: 0.944, 95% CI: 0.692–1.288, p = 0.721), and weighted median method (OR: 0.900, 95% CI: 0.678–1.194, p = 0.449). Additionally, the same analysis was conducted for the meta-analysis database, and we found no significant association (OR: 1.000, 95% CI: 0.999–1.001, p = 0.683).ConclusionOur findings reveal no significant causal association between circulating ADPN and AD risk.
first_indexed 2024-04-11T06:17:37Z
format Article
id doaj.art-9650675840f74d2eb718b0ef2d4e7fc2
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-04-11T06:17:37Z
publishDate 2022-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-9650675840f74d2eb718b0ef2d4e7fc22022-12-22T04:41:01ZengFrontiers Media S.A.Frontiers in Neurology1664-22952022-12-011310.3389/fneur.2022.10389751038975Causal association between adiponectin and the risk of Alzheimer's disease: A Mendelian randomization studyTianyu Jin0Tianyu Jin1Wei Huang2Fangzheng Cao3Xinyue Yu4Zhenhua Ying5Shunyuan Guo6Yifan Cheng7Chao Xu8The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, ChinaCenter for Rehabilitation Medicine, Department of Neurology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, ChinaRheumatism and Immunity Research Institute, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, ChinaThe Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, ChinaAlberta Institute, Wenzhou Medical University, Wenzhou, ChinaRheumatism and Immunity Research Institute, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, ChinaCenter for Rehabilitation Medicine, Department of Neurology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, ChinaCenter for Rehabilitation Medicine, Department of Neurology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, ChinaCenter for Rehabilitation Medicine, Department of Neurology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, ChinaBackgroundNumerous observational studies have revealed that circulating adiponectin (ADPN) is associated with Alzheimer's disease (AD) risk. However, the causality remains unknown. We aimed to assess the causality of circulating ADPN on AD risk using Mendelian randomization (MR).MethodsFourteen single nucleotide polymorphisms (SNPs) significantly associated with ADPN were selected from publicly available genetic abstract data. We applied these SNPs to two recent large-scale genome-wide association studies (GWAS) of AD, one from the FinnGen consortium and the other from a large meta-analysis. The inverse variance weighted method, MR–Egger method, the weighted median method, the Cochran Q statistic, the MR-Pleiotropy Residual Sum and Outlier methods, and the leave-one-out analysis were applied for MR analyses.ResultsIn MR analysis, no significant genetic association was found between plasma ADPN levels and AD risk by analyzing the FinnGen consortium GWAS database in the inverse variance weighted method [odds ratio (OR): 0.874, 95% confidence interval (CI): 0.701–1.089, p = 0.230], MR–Egger (OR: 0.944, 95% CI: 0.692–1.288, p = 0.721), and weighted median method (OR: 0.900, 95% CI: 0.678–1.194, p = 0.449). Additionally, the same analysis was conducted for the meta-analysis database, and we found no significant association (OR: 1.000, 95% CI: 0.999–1.001, p = 0.683).ConclusionOur findings reveal no significant causal association between circulating ADPN and AD risk.https://www.frontiersin.org/articles/10.3389/fneur.2022.1038975/fullAlzheimer's diseaseadiponectincausalityMendelian randomizationrisk
spellingShingle Tianyu Jin
Tianyu Jin
Wei Huang
Fangzheng Cao
Xinyue Yu
Zhenhua Ying
Shunyuan Guo
Yifan Cheng
Chao Xu
Causal association between adiponectin and the risk of Alzheimer's disease: A Mendelian randomization study
Frontiers in Neurology
Alzheimer's disease
adiponectin
causality
Mendelian randomization
risk
title Causal association between adiponectin and the risk of Alzheimer's disease: A Mendelian randomization study
title_full Causal association between adiponectin and the risk of Alzheimer's disease: A Mendelian randomization study
title_fullStr Causal association between adiponectin and the risk of Alzheimer's disease: A Mendelian randomization study
title_full_unstemmed Causal association between adiponectin and the risk of Alzheimer's disease: A Mendelian randomization study
title_short Causal association between adiponectin and the risk of Alzheimer's disease: A Mendelian randomization study
title_sort causal association between adiponectin and the risk of alzheimer s disease a mendelian randomization study
topic Alzheimer's disease
adiponectin
causality
Mendelian randomization
risk
url https://www.frontiersin.org/articles/10.3389/fneur.2022.1038975/full
work_keys_str_mv AT tianyujin causalassociationbetweenadiponectinandtheriskofalzheimersdiseaseamendelianrandomizationstudy
AT tianyujin causalassociationbetweenadiponectinandtheriskofalzheimersdiseaseamendelianrandomizationstudy
AT weihuang causalassociationbetweenadiponectinandtheriskofalzheimersdiseaseamendelianrandomizationstudy
AT fangzhengcao causalassociationbetweenadiponectinandtheriskofalzheimersdiseaseamendelianrandomizationstudy
AT xinyueyu causalassociationbetweenadiponectinandtheriskofalzheimersdiseaseamendelianrandomizationstudy
AT zhenhuaying causalassociationbetweenadiponectinandtheriskofalzheimersdiseaseamendelianrandomizationstudy
AT shunyuanguo causalassociationbetweenadiponectinandtheriskofalzheimersdiseaseamendelianrandomizationstudy
AT yifancheng causalassociationbetweenadiponectinandtheriskofalzheimersdiseaseamendelianrandomizationstudy
AT chaoxu causalassociationbetweenadiponectinandtheriskofalzheimersdiseaseamendelianrandomizationstudy